(PRWEB) November 17, 2013
Pharmaceuticals report: “Alzheimers Disease Therapeutics Market to 2019 – Early Stage Innovation Points to Disease Modifying Therapies and Market Transformation”. The Alzheimers Disease (AD) market is characterized by a lack of products with strong disease-modifying properties and a number of high-profile product failures in late stages of development over recent years. In addition, recent or impending patent expiries for all of the four currently marketed products and a late-stage pipeline with limited-to-moderate prospects are expected to impede growth over the next few years.
To check out the complete table of contents, visit: http://www.marketresearchreports.biz/analysis-details/alzheimers-disease-therapeutics-market-to-2019-early-stage-innovation-points-to-disease-modifying-therapies-and-market-transformation.
In the medium-term future, the market is expected to be characterized by substantial generic competition and overall decline.
However, the current development pipeline shows signs of meaningful innovation, although the vast majority of these products are currently in the early stages of development. Despite one of the highest drug attrition rates across the industry, a number of innovative and potentially disease-modifying therapeutics are likely to enter the market and translate recent insights into the etiology of AD combined with an earlier therapeutic intervention into better products, which will begin to transform the AD market towards the end of the decade.
A brief introduction to AD etiology, pathogenesis, diagnosis, and treatment regimes
Profiling of the marketed products in the AD market, including analysis of their safety, efficacy, treatment patterns, and strengths and weaknesses
Comprehensive review of the pipeline for AD therapies, including individual analysis of a number of late-stage pipeline drugs that are likely to enter the market during the forecast period. The pipeline is analyzed on the basis of phase distribution, molecule type, and molecular target.
Additional in-depth analysis of pipeline drug clinical trials, analyzed by phase, molecule type, trial size, trial duration and program failure rate, for each molecule type and mechanism of action
Multi-scenario forecast data for the market to 2019, taking into account how it will be affected by the introduction of new drugs, the expiry of key patents on current drugs, and changes in disease epidemiology across the key developed markets of the US, Japan, Germany, the UK, France, Italy and Spain
Discussion of the drivers of and barriers to market growth
Analysis of the licensing and co-development deals landscape
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/178526
Reasons to Buy
Understand the different levels of AD therapies, from early-stage or mild AD to severe AD
Understand the vast scope of the pipeline, including which molecule types and mechanisms of action are prominent
Observe trends in terms of clinical trial duration and size among clinical phases and molecule types, and use the clinical trial failure rate analysis to assess the risk profiles of current and/or future developmental programs for AD therapeutics
Table of Content
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2.3.2 Tau Hyperphosphorylation
To buy the copy of this report, visit: http://www.marketresearchreports.biz/analysis/178526.
3 Marketed Products
3.1 Namenda/Axura/Memary (memantine), Merz Pharma/Lundbeck/Forest Laboratories/Daiichi Sankyo
3.2 Aricept (donepezil), Eisai Inc.
3.3 Exelon (rivastigmine), Novartis AG
3.4 Razadyne (galantamine), Janssen Pharmaceuticals
3.5 Cognex (tacrine), Shiniogi Inc.
3.6 Unmet Need
4 Pipeline for Alzheimers Disease Therapeutics
4.1 Overall Pipeline
4.2 Mechanisms of Action within the AD Pipeline
4.3 Clinical Trials
4.3.1 Clinical Trial Failure Rate
4.3.2 Clinical Trial Size
5 Market Forecast to 2019
5.1 Geographical Markets
5.1.1 Key Developed Markets
5.1.3 Leading Five EU Countries (EU5)
Global Medical Antimicrobial Coatings Market 2012-2016
Global Medical Antimicrobial Coatings market to grow at a CAGR of 11.42 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of hospital-acquired infection. The Global Medical Antimicrobial Coatings market has also been witnessing increasing partnership activities among vendors. However, the stringent regulation policies could pose a challenge to the growth of this market.
Global Medical Antimicrobial Coatings Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Medical Antimicrobial Coatings market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
To buy the copy of this report, visit: http://www.marketresearchreports.biz/sample/sample/179017.
The key vendors dominating this market space are BASF SE, Covalon Technologies Ltd., Hydromer Inc., Royal DSM N.V, and Sono-Tek Corp.
Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
TABLE OF CONTENT
1. Executive Summary
2. Scope of the Report
2.1 Market Overview
2.2 Product Offerings
3. Market Research Methodology
3.1 Market Research Process
3.2 Research Design
3.3 Research Methodology
4. List of Abbreviations
6. Market Landscape
6.1 Market Overview
6.1.1 Market Size and Forecast
6.2 Five Forces Analysis
Containers And Packaging Market In The US 2012-2016
The Containers and Packaging market in the US to grow at a CAGR of 2.70 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for convenience in packages. The Containers and Packaging market in the US has also been witnessing the increasing demand for plastic material in packaging products. However, the highly fragmented market could pose a challenge to the growth of this market.
The Containers and Packaging Market in the US 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report focuses on the US; it also covers the Containers and Packaging market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
To buy the copy of this report, visit: h